Finance

Beta
Lists
353810:KOSDAQ
Easy Bio Inc
₩6,410.00
-2.58%
(-170.00) 1D
Jun 10, 1:11:00 PM GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 353810...
Open
₩6,620
High
₩6,620
Low
₩6,350
Mkt. cap
212.06B
Avg. vol.
184.33K
Volume
56.42K
Dividend
3.90%
Quarterly dividend
₩62
Ex-dividend date
Mar 9, 2026
P/E ratio
6.35
52-wk high
₩8,560
52-wk low
₩4,885
EPS
₩1,010
Shares outstanding
33.08M
No. of employees
132
Open
₩6,620
High
₩6,620
Low
₩6,350
Mkt. cap
212.06B
Avg. vol.
184.33K
Volume
56.42K
Dividend
3.90%
Quarterly dividend
₩62
Ex-dividend date
Mar 9, 2026
P/E ratio
6.35
52-wk high
₩8,560
52-wk low
₩4,885
EPS
₩1,010
Shares outstanding
33.08M
No. of employees
132
News stories
From sources across the web
About Easy Bio Inc
CEO-
Employees132
Founded2011
Headquarters-
SectorFood
Websiteeasybio.co.kr
Previous reportsAll values in KRW
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in KRW
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
113.79B
116.90B
129.32B
130.69B
Cost of goods sold
85.56B
86.92B
93.65B
95.95B
Cost of revenue
85.56B
86.92B
93.65B
95.95B
Research and development expenses
754.12M
749.16M
916.09M
996.55M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
15.28B
16.70B
19.25B
18.62B
Operating expense
17.18B
18.73B
22.07B
21.53B
Total operating expenses
102.75B
105.65B
115.73B
117.47B
Operating income
11.05B
11.25B
13.59B
13.22B
Other non operating income
-274.55M
-212.73M
-194.45M
-275.62M
EBT including unusual items
5.30B
11.65B
13.76B
15.65B
EBT excluding unusual items
5.14B
11.49B
13.43B
15.29B
Income tax expense
1.20B
3.02B
3.00B
3.98B
Effective tax rate
22.58%
25.88%
21.77%
25.44%
Other operating expenses
346.42M
556.51M
554.85M
981.47M
Net income
3.79B
8.31B
10.13B
11.19B
Net profit margin
3.33%
7.11%
7.83%
8.56%
Earnings per share
-
-
-
-
Interest and investment income
505.15M
491.14M
544.93M
526.32M
Interest expense
-1.97B
-1.51B
-1.61B
-1.55B
Net interest expenses
-1.46B
-1.02B
-1.06B
-1.03B
Depreciation and amortization charges
277.28M
277.74M
303.42M
302.80M
EBITDA
13.12B
13.28B
15.72B
15.34B
Gain or loss from assets sale
-648.00K
-481.00K
-3.63M
63.74M
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer